Associations of the PTEN -9C>G polymorphism with insulin sensitivity and central obesity in Chinese

Gene

Volumn 527, Issue 2, 2013, Pages 545-552

  Yang, Qiu ^a   Cao, Hongyi ^b   Xie, Shugui ^c   Tong, Yuzhen ^a   Zhu, Qibo ^a   Zhang, Fang ^a   Lü, Qingguo ^a   Yang, Yan ^a   Li, Daigang ^d   Chen, Mei ^c   Yu, Changyong ^c   Jin, Wei ^c   Yuan, Yuquan ^c   Tong, Nanwei ^a  

^a SICHUAN UNIVERSITY   (China)

^b CHENGDU FIFTH PEOPLE S HOSPITAL   (China)

^c Chengdu General Hospital   (China)

^d Chengdu Yincao Community Hospital   (China)

Author keywords

Central obesity; Insulin resistance; Metabolic syndrome; PTEN; SNP

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CASE CONTROL STUDY; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GENDER; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLIC SYNDROME X; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST TO HEIGHT RATIO;

ANALYSIS OF VARIANCE; ANOVA; BMI; BODY MASS INDEX; CARDIOVASCULAR DISEASE; CENTRAL OBESITY; CI; CONFIDENCE INTERVAL; CVD; DM; GLYCATED HEMOGLOBIN; HBA1C; HOMA-Β; HOMA-IR; HOMEOSTASIS MODEL ASSESSMENTS OF Β-CELL FUNCTION; HOMEOSTASIS MODEL ASSESSMENTS OF INSULIN RESISTANCE; INSULIN RESISTANCE; IR; MALDI-TOF MS; MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MATSUDA INSULIN SENSITIVITY INDEX; MATSUDA ISI; METABOLIC SYNDROME; METS; MMAC1; MULTIPLE ADVANCED CANCERS 1; NAFLD; NGT; NONALCOHOLIC FATTY LIVER DISEASE; NORMAL GLUCOSE TOLERANCE; ODDS RATIO; OGTT; OR; ORAL GLUCOSE TOLERANCE TEST; PD; PHOSPHATASE AND TENSIN HOMOLOG ON CHROMOSOME 10; PHOSPHATIDYLINOSITOL (PI) 3-KINASE; PHOSPHATIDYLINOSITOL-3,4,5-TRISPHOSPHATE; PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE; PI3K; PIP2; PIP3; PKA; PKC; PREDIABETES; PROTEIN KINASE A; PROTEIN KINASE C; PTEN; SINGLE NUCLEOTIDE POLYMORPHISM; SNP; TEP1; TGFΒ-REGULATED AND EPITHELIAL CELL-ENRICHED PHOSPHATASE 1; TYPE 2 DIABETES MELLITUS; WAIST CIRCUMFERENCE; WAIST CIRCUMFERENCE/HEIGHT; WC; WHTR;

AGED; CASE-CONTROL STUDIES; CHINA; COHORT STUDIES; GENE FREQUENCY; GENOTYPE; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; OBESITY, ABDOMINAL; POLYMORPHISM, GENETIC; PTEN PHOSPHOHYDROLASE;

EID: 84881557806     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.06.026     Document Type: Article

References (35)

1. Alberti K.G., Zimmet P., Shaw J. The metabolic syndrome: a new worldwide definition. Lancet 2005, 366:1059-1062.
2. Antonio G.R., et al. Nutrigenetics of the lipoprotein metabolism. Mol. Nutr. Food Res. 2012, 56:171-183.
3. Butler M., et al. Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes 2002, 51:1028-1034.
4. DeNino W.F., et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy non-obese women. Diabetes Care 2001, 24:925-932.
5. Eckle R.H., Grundy S.M., Zimmet P.Z. The metabolism syndrome. Lancet 2005, 365:1415-1428.
6. Gauderman W.J. Sample size requirements for matched case-control studies of gene-environment interaction. Stat. Med. 2002, 21:35-50.
7. Genuth S., et al. (Expert Committee on the Diagnosis and Classification of Diabetes Mellitus) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
8. Grundy S., Cleeman J., Daniels S. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005, 112:2735-2752.
9. Hamada K., et al. The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis. Genes Dev. 2005, 19:2054-2065.
10. Hansen L., et al. Studies of variability in the PTEN gene among Danish Caucasian patients with type II diabetes mellitus. Diabetologia 2001, 44:237-240.
11. Hong Y., et al. Genetic and environmental architecture of the features of the insulin-resistance syndrome. Am. J. Hum. Genet. 1997, 60:143-152.
12. Ishihara H., et al. Association of the polymorphisms in the 5 '-untranslated region of PTEN gene with type 2 diabetes in a Japanese population. FEBS Lett. 2003, 554:450-454.
13. Kurlawalla-Martinez C., Stiles B., Wang Y. Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue. Mol. Cell. Biol. 2005, 25:2498-2510.
14. Lee J., et al. Should central obesity be an optional or essential component of the metabolic syndrome? Ischemic heart disease risk in the Singapore Cardiovascular Cohort Study. Diabetes Care 2007, 30:343-347.
15. Lenin M., et al. Mesangial cell hypertrophy by high glucose is mediated by downregulation of the tumor suppressor PTEN. Diabetes 2006, 55:2115-2125.
16. Maehama T., Taylor G.S., Dixon J.E. PTEN and myotubularin: novel phosphoinositide phosphatases. Annu. Rev. Biochem. 2001, 70:247-279.
17. Martin H., et al. The impact of genetic variation in theG6PC2 gene on insulin secretion depends on glycemia. J. Clin. Endocrinol. Metab. 2010, 95:E479-E484.
18. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999, 22:1462-1470.
19. Miljkovic I., et al. Abdominal myosteatosis is independently associated to hyperinsulinemia and insulin resistance among older men without diabetes. Obesity (Silver Spring) 2013, (Feb 14. Epub ahead of print). 10.1002/oby.20346.
20. Miyake K., et al. Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver. J. Clin. Invest. 2002, 110:1483-1491.
21. Nakashima N., et al. The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 rated human endothelial cells. J. Biol. Chem. 2006, 281:7727-7736.
22. Niswender K.D., Baskin D.G., Schwartz M.W. Insulin and its evolving partnership with leptin in the hypothalamic control of energy homeostasis. Trends Endocrinol. Metab. 2004, 15:362-369.
23. Park H.S., et al. Prevalence and trends of metabolic syndrome in Korea: Korean National Health and Nutrition Survey 1998-2001. Diabetes Obes. Metab. 2007, 9:50-58.
24. Saltiel A.R., Kahn C.R. Insulin signaling and the regulation of glucose and lipid metabolism. Nature 2002, 414:799-806.
25. Shao J., et al. Waist-to-height ratio, an optimal predictor for obesity and metabolic syndrome in Chinese adults. J. Nutr. Health Aging 2010, 14:782-785.
26. Stambolic V., et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998, 95:29-39.
27. Steck P.A., et al. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 1997, 15:356-362.
28. Stiles B., Wang Y., Stahl A. Liver-specific deletion of negative regulator PTEN results in fatty liver and insulin hypersensitivity. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:2082-2087.
29. Taniguchi C.M., Emanuelli B., Kahn C.R. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 2006, 7:85-96.
30. Thomas G.N., et al. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res. Clin. Pract. 2005, 67:251-257.
31. Wallace T.M., Levy J.C., Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495.
32. White M.F. IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 2002, 283:E413-E422.
33. Xu A.W., et al. PI3K integrates the action of insulin and leptin on hypothalamic neurons. J. Clin. Invest. 2005, 115:951-958.
34. Yamada K.M., Araki M. Tumor suppress or PTEN: modulator of cell signaling, growth, migration and apoptosis. J. Cell Sci. 2001, 114:2375-2382.
35. Zamboni M., et al. Effects of age on body fat distribution and cardiovascular risk factors in women. Am. J. Clin. Nutr. 1997, 66:111-115.